Ragonese M - Search Results

1

Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer.

Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi P. Racioppi M, et al. Among authors: ragonese m. Eur Urol Oncol. 2019 Sep;2(5):576-583. doi: 10.1016/j.euo.2018.08.032. Epub 2018 Oct 6. Eur Urol Oncol. 2019. PMID: 31411974 Clinical Trial.

2

[Innovative treatments of non muscle invasive bladder cancer].

Racioppi M, D'Agostino D, Pugliese D, Ragonese M, Di Gianfrancesco L, Bassi P. Racioppi M, et al. Among authors: ragonese m. Urologia. 2013 Apr-Jun;80(2):120-6. doi: 10.5301/RU.2013.11302. Epub 2013 Jul 5. Urologia. 2013. PMID: 23852929 Italian.

3

NBI: results review.

Racioppi M, D'Agostino D, Ragonese M, Gianfrancesco LD, Bassi PF. Racioppi M, et al. Among authors: ragonese m. Urologia. 2015 Oct;82 Suppl 2:S9-11. doi: 10.5301/uro.5000155. Epub 2015 Oct 9. Urologia. 2015. PMID: 26481720 Review.

4

The occult urothelial cancer.

Ragonese M, Racioppi M, D'Agostino D, Di Gianfrancesco L, Lenci N, Bientinesi R, Palermo G, Sacco E, Pinto F, Bassi PF. Ragonese M, et al. Urologia. 2016 May 24;83(2):55-60. doi: 10.5301/uro.5000131. Epub 2016 Mar 14. Urologia. 2016. PMID: 26481721 Review. English.

5

Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review.

Bientinesi R, Ragonese M, Pinto F, Bassi PF, Sacco E. Bientinesi R, et al. Among authors: ragonese m. Clin Genitourin Cancer. 2016 Apr;14(2):e199-201. doi: 10.1016/j.clgc.2015.11.010. Epub 2015 Nov 17. Clin Genitourin Cancer. 2016. PMID: 26707952 Review. No abstract available.

6

Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up.

D''Agostino D, Racioppi M, Pugliese D, Ragonese M, Di Gianfrancesco L, Filianoti A, Palermo G, Belgrano E, Siracusano S, Niero M, Imbimbo C, Iafrate M, Artibani W, Cerruto MA, Talamini R, Bassi P. D''Agostino D, et al. Among authors: ragonese m. Urol Int. 2016;97(1):54-60. doi: 10.1159/000443185. Epub 2016 Apr 12. Urol Int. 2016. PMID: 27064910

7

Mitomycin C: new strategies to improve efficacy of a well-known therapy.

Ragonese M, Racioppi M, Bassi PF, Di Gianfrancesco L, Lenci N, Filianoti A, Recupero SM. Ragonese M, et al. Urologia. 2016 Oct 4;83(Suppl 2):24-28. doi: 10.5301/uro.5000193. Epub 2016 Oct 1. Urologia. 2016. PMID: 27647081 Review.

8

The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients.

Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi P. Racioppi M, et al. Among authors: ragonese m. J Geriatr Oncol. 2018 Sep;9(5):507-512. doi: 10.1016/j.jgo.2018.03.020. Epub 2018 Apr 16. J Geriatr Oncol. 2018. PMID: 29673806

9

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes.

Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi PF. Racioppi M, et al. Among authors: ragonese m. BMC Cancer. 2018 Dec 6;18(1):1224. doi: 10.1186/s12885-018-5134-7. BMC Cancer. 2018. PMID: 30522445 Free PMC article. Clinical Trial.

10

Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?

Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi PF. Racioppi M, et al. Among authors: ragonese m. Int Braz J Urol. 2019 Mar-Apr;45(2):315-324. doi: 10.1590/S1677-5538.IBJU.2018.0249. Int Braz J Urol. 2019. PMID: 30785697 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters